Morgan Lewis IP litigators aggressively represent our clients' interests in patent, trademark, copyright, trade secret, and related intellectual property (including unfair competition) matters. Our Intellectual Property Litigation Practice is tightly integrated into our global Litigation Practice, which draws on the strength of some 700 litigation-focused lawyers throughout our U.S. and foreign offices.
We have litigated numerous cases in federal court at both the trial and appellate levels, including the federal courts in 35 states. Clients also benefit from our substantial experience before the International Trade Commission in Section 337 proceedings, and before the U.S. Patent and Trademark Office in inter partes and interference proceedings.
Morgan Lewis’s IP Litigation Practice includes a core team of more than 60 patent litigators. These patent litigators have collectively and successfully tried scores of cases to verdict, including both jury and bench trials. Our lawyers also have been successful in preliminary injunction proceedings, in appellate proceedings before the U.S. Court of Appeals for the Federal Circuit, and in conducting “Markman” hearings. We have experience in many specialized areas, including handling Hatch-Waxman Act (“ANDA”) cases on behalf of some of the world’s leading innovator pharmaceutical companies.
Our successes are not limited to the courtroom. Through aggressive litigation, we have also successfully positioned cases for beneficial settlement. Similarly, our intellectual property and patent litigators have arbitrated and mediated on behalf of some of the world’s most profitable and innovative intellectual property-driven companies, achieving remarkable successes for them in domestic and international disputes.
Our intellectual property and patent litigators are located in offices throughout the United States and in Tokyo and Beijing, providing clients with seamless global access to any services they need.